A UK-wide clinical study has confirmed the findings of an earlier Oxford BRC-supported study showing that the early treatment with the inhaled asthma medication budesonide speeds up recovery from COVID-19…
Search results
Common asthma treatment reduces need for hospitalisation in COVID-19 patients, study suggests
…Oxford have found. 146 people took part in the trial. The STOIC study found that inhaled budesonide given to patients with COVID-19 within seven days of the onset of symptoms…
budesonide_3_cropped
budesonide_3_cropped
budesonide_3_cropped
Budesonide-pic-11.2.2021-06
Oxford University and ZOE partner on COVID-19 treatment trials
…STOIC trial, which is supported by the NIHR Oxford BRC. Run by the University’s Nuffield Department of Medicine (NDM), it is aiming to learn if the inhaled steroid Budesonide works…
COVID-19 Research Case Studies
…and hospitalisation in people with COVID-19. The STOIC study found that inhaled budesonide given to patients with COVID-19 within seven days of the onset of symptoms also reduced recovery time….